125 related articles for article (PubMed ID: 7512763)
1. The pore-forming peptide of Entamoeba histolytica, the protozoan parasite causing human amoebiasis.
Leippe M; Müller-Eberhard HJ
Toxicology; 1994 Feb; 87(1-3):5-18. PubMed ID: 7512763
[TBL] [Abstract][Full Text] [Related]
2. Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica.
Leippe M; Andrä J; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2602-6. PubMed ID: 8146160
[TBL] [Abstract][Full Text] [Related]
3. Amoebapores, a family of membranolytic peptides from cytoplasmic granules of Entamoeba histolytica: isolation, primary structure, and pore formation in bacterial cytoplasmic membranes.
Leippe M; Andrä J; Nickel R; Tannich E; Müller-Eberhard HJ
Mol Microbiol; 1994 Dec; 14(5):895-904. PubMed ID: 7715451
[TBL] [Abstract][Full Text] [Related]
4. Pore-forming peptides of Entamoeba dispar. Similarity and divergence to amoebapores in structure, expression and activity.
Nickel R; Ott C; Dandekar T; Leippe M
Eur J Biochem; 1999 Nov; 265(3):1002-7. PubMed ID: 10518795
[TBL] [Abstract][Full Text] [Related]
5. Comparison of pore-forming peptides from pathogenic and nonpathogenic Entamoeba histolytica.
Leippe M; Bahr E; Tannich E; Horstmann RD
Mol Biochem Parasitol; 1993 May; 59(1):101-9. PubMed ID: 8515772
[TBL] [Abstract][Full Text] [Related]
6. Primary and secondary structure of the pore-forming peptide of pathogenic Entamoeba histolytica.
Leippe M; Tannich E; Nickel R; van der Goot G; Pattus F; Horstmann RD; Müller-Eberhard HJ
EMBO J; 1992 Oct; 11(10):3501-6. PubMed ID: 1396552
[TBL] [Abstract][Full Text] [Related]
7. Pore-forming peptide of Entamoeba histolytica. Significance of positively charged amino acid residues for its mode of action.
Andrä J; Leippe M
FEBS Lett; 1994 Oct; 354(1):97-102. PubMed ID: 7525351
[TBL] [Abstract][Full Text] [Related]
8. Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence.
Bracha R; Nuchamowitz Y; Leippe M; Mirelman D
Mol Microbiol; 1999 Nov; 34(3):463-72. PubMed ID: 10564488
[TBL] [Abstract][Full Text] [Related]
9. Membrane perforation by Entamoeba histolytica: structural implications derived from the sequence of the pore-forming peptide.
Leippe M
Arch Med Res; 1992; 23(2):35-7. PubMed ID: 1285083
[TBL] [Abstract][Full Text] [Related]
10. Shortened amoebapore analogs with enhanced antibacterial and cytolytic activity.
Andrä J; Berninghausen O; Wülfken J; Leippe M
FEBS Lett; 1996 Apr; 385(1-2):96-100. PubMed ID: 8641476
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of the pore-forming protein of Entamoeba histolytica.
Hecht O; Van Nuland NA; Schleinkofer K; Dingley AJ; Bruhn H; Leippe M; Grötzinger J
J Biol Chem; 2004 Apr; 279(17):17834-41. PubMed ID: 14970207
[TBL] [Abstract][Full Text] [Related]
12. Host tissue destruction by Entamoeba histolytica: molecules mediating adhesion, cytolysis, and proteolysis.
Horstmann RD; Leippe M; Tannich E
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():57-60. PubMed ID: 1342717
[TBL] [Abstract][Full Text] [Related]
13. [Recent findings on the pathogenicity of Entamoeba histolytica].
Tannich E; Leippe M; Horstmann RD
Immun Infekt; 1992 Oct; 20(5):146-50. PubMed ID: 1452192
[TBL] [Abstract][Full Text] [Related]
14. Cell-free synthesis and combinatorial selective 15N-labeling of the cytotoxic protein amoebapore A from Entamoeba histolytica.
Xun Y; Tremouilhac P; Carraher C; Gelhaus C; Ozawa K; Otting G; Dixon NE; Leippe M; Grötzinger J; Dingley AJ; Kralicek AV
Protein Expr Purif; 2009 Nov; 68(1):22-7. PubMed ID: 19573603
[TBL] [Abstract][Full Text] [Related]
15. Pore-forming peptide of pathogenic Entamoeba histolytica.
Leippe M; Ebel S; Schoenberger OL; Horstmann RD; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7659-63. PubMed ID: 1881907
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous release of cysteine proteinases but not of pore-forming peptides by viable Entamoeba histolytica.
Leippe M; Sievertsen HJ; Tannich E; Horstmann RD
Parasitology; 1995 Dec; 111 ( Pt 5)():569-74. PubMed ID: 8559589
[TBL] [Abstract][Full Text] [Related]
17. Genomic DNA differences between pathogenic and nonpathogenic Entamoeba histolytica.
Tannich E; Horstmann RD; Knobloch J; Arnold HH
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5118-22. PubMed ID: 2544890
[TBL] [Abstract][Full Text] [Related]
18. Membrane lipid composition protects Entamoeba histolytica from self-destruction by its pore-forming toxins.
Andrä J; Berninghausen O; Leippe M
FEBS Lett; 2004 Apr; 564(1-2):109-15. PubMed ID: 15094050
[TBL] [Abstract][Full Text] [Related]
19. Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 19 February 1998. Amoebic disease. Entamoeba histolytica and E. dispar: comparison of molecules considered important for host tissue destruction.
Tannich E
Trans R Soc Trop Med Hyg; 1998; 92(6):593-6. PubMed ID: 10326098
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in the molecular biology of Entamoeba histolytica.
Horstmann RD; Leippe M; Tannich E
Trop Med Parasitol; 1992 Dec; 43(4):213-8. PubMed ID: 1338130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
